Vulvar Vaginal Atrophy Therapy Market: How Is Non-Hormonal Therapy Reshaping Treatment Access for Breast Cancer Survivors?
Non-hormonal vulvar vaginal atrophy therapies — the estrogen-free treatment options including selective estrogen receptor modulators (ospemifene), vaginal dehydroepiandrosterone (prasterone), moisturizers, lubricants, and laser therapies enabling symptom relief for women with hormone-sensitive cancer history or contraindications to estrogen — represent the fastest-growing therapy...
0 Comments 0 Shares 86 Views